Corbus Pharmaceuticals Announces Publication of Two Abstracts at EULAR 2020 E-Congress

Corbus Pharmaceuticals Announces Publication of Two Abstracts at EULAR 2020 E-Congress

Corbus Pharmaceuticals Holdings, Inc., a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced the publication of two abstracts at the European League Against Rheumatism (EULAR) 2020 E-Congress that will be taking place June 3-6, 2020.Read more >>

Share this post